ICICI Lombard General Insurance Company announced 9MFY25 & Q3FY25 results Q3FY25 Financial Highlights: GDPI of the Company was at Rs 62.14 billion in Q3FY25 as against Rs 62.30 billion in Q3FY24, a de-growth of 0.3%, as against the industry growth of 9.5%. Excluding the impact of 1/n, GDPI of the Company grew by 4.8% for Q3FY25. Combined ratio was at 102.7% in Q3FY25 as against 103.6% in Q3FY24. PBT grew at 67.3% to Rs 9.60 billion in Q3FY25 as against Rs 5.74 billion in Q3FY24. Capital gains was at Rs 2.76 billion in Q3FY25 as against Rs 1.08 billion in Q3FY24. PAT grew at 67.9% to Rs 7.24 billion in Q3FY25 from Rs 4.31 billion in Q3FY24. ROAE was at 21.5% in Q3FY25 compared to 15.3% in Q3FY24. 9MFY25 Financial Highlights: Gross Direct Premium Income (GDPI) of the Company was at Rs 206.23 billion in 9MFY25 compared to Rs 187.03 billion in 9MFY24, a growth of 10.3%, which was higher than the industry growth of 7.8%. Excluding the impact of 1/n, GDPI of the Company grew by 11.9% for 9MFY25. Combined ratio was at 102.9% for 9MFY25 compared to 103.7% for 9MFY24. Profit before tax (PBT) grew at 42.8% to Rs 26.53 billion in 9MFY25 as against Rs 18.57 billion in 9MFY24. Capital gains was at Rs 7.96 billion in 9MFY25 as against Rs 3.95 billion in 9MFY24. Consequently, Profit after tax (PAT) grew at 42.9% to Rs 19.99 billion in 9MFY25 as against Rs 13.99 billion in 9MFY24. Return on Average Equity (ROAE) was at 20.8% in 9MFY25 compared to 17.1% in 9MFY24 Solvency ratio was 2.36x as at December 31, 2024 as against 2.65x as at September 30, 2024 and higher than the minimum regulatory requirement of 1.50x. Solvency ratio was 2.62x as at March 31, 2024. Result PDF
General Insurance company ICICI Lombard General Insurance Company announced H1FY25 & Q2FY25 results Q2FY25 Financial Highilights: GDPI of the Company was at Rs 67.21 billion in Q2FY25 as against Rs 60.86 billion in Q2FY24, growth of 10.4%. This growth was higher than industry growth of 2.0%. Excluding crop and mass health, GDPI growth of the Company was at 9.4%, which was higher than the industry growth of 6.9% in Q2FY25. Combined ratio stood at 104.5% in Q2FY25 as against 103.9% in Q2FY24. Excluding the impact of CAT losses of Rs 0.94 billion in Q2FY25 and Rs 0.48 billion in Q2FY24, the combined ratio was 102.6% and 102.8% respectively Capital gains were at Rs 5.21 billion in H1FY25 as against Rs 2.87 billion in H1FY24. Capital gains were at Rs 2.37 billion in Q2FY25 as against Rs 1.65 billion in Q2FY24. H1FY25 Financial Highilights: Gross Direct Premium Income (GDPI) of the Company stood at Rs 144.09 billion in H1FY25 compared to Rs 124.72 billion in H1FY24, a growth of 15.5%, which was higher than the industry growth of 7.0%. Excluding crop and mass health, GDPI growth of the Company was at 15.0%, which was higher than the industry growth of 10.9% in H1FY25. Combined ratio stood at 103.2% for H1FY25 compared to 103.8% for H1FY24. Excluding the impact of CAT losses of Rs 0.94 billion in H1FY25 and Rs 0.83 billion in H1FY24, the combined ratio was 102.2% and 102.7% respectively. Profit before tax (PBT) grew by 31.9% to Rs 16.93 billion in H1FY25 as against Rs 12.84 billion in H1FY24 whereas PBT grew by 20.3% to Rs 9.19 billion in Q2FY25 as against Rs 7.64 billion in Q2FY24. Consequently, Profit after tax (PAT) grew by 31.7% to Rs 12.74 billion in H1FY25 as against Rs 9.68 billion in H1FY24. PAT grew by 20.2% to Rs 6.94 billion in Q2FY25 from Rs 5.77 billion in Q2FY24. Return on Average Equity (ROAE) was 20.3% in H1FY25 compared to 18.0% in H1FY24 while ROAE was 21.8% in Q2FY25 compared to 21.1% in Q2FY24. Solvency ratio was 2.65x as at Q2FY25 as against 2.56x as at June 30, 2024 and higher than the minimum regulatory requirement of 1.50x. Solvency ratio was 2.62x as at FY24. The Board of Directors of the company has declared interim dividend of Rs 5.50 per share for H1FY25 as against Rs 5.00 for H1FY24. Result PDF